Stay updated on Foralumab Safety in NASH and T2DM Clinical Trial
Sign up to get notified when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.

Latest updates to the Foralumab Safety in NASH and T2DM Clinical Trial page
- Check2 days agoChange DetectedA new revision entry, Revision: v3.5.5, was added to the study record history, replacing the previous Revision: v3.5.4. This indicates an update to the record's documentation.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision entry (v3.5.4) is added to the study record history, replacing the previous v3.5.3 to reflect an update in the page's revision history.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page footer/UI now reflects a newer site build revision (v3.5.3 instead of v3.5.2) without changing the displayed clinical trial history details.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded revision v3.5.2 to the study record history and removed revision v3.5.0.SummaryDifference0.1%

- Check80 days agoChange DetectedRecord history shows revision v3.5.0 added and revision v3.4.3 removed.SummaryDifference0.1%

- Check95 days agoChange DetectedThe history now includes revision v3.4.3, while revision v3.4.2 is removed.SummaryDifference0.1%

Stay in the know with updates to Foralumab Safety in NASH and T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.